Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel one-step carbonylation method for bioactive furanones. High yield, scalable process for reliable pharmaceutical intermediate supply chain optimization.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Patent CN111423381B reveals a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN115232163B reveals a transition-metal-free NHC catalytic route for silicon-centered chiral compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN115872914A details a base-mediated cyclization of aryl-1-propynes and nitriles. Offers high purity, metal-free route for reliable pharmaceutical intermediate supply chain.
Patent CN116715699B reveals manganese-based asymmetric hydrogenation. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN116813544B reveals catalyst-free heating method. Delivers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN114634482B introduces a novel hypervalent iodine-mediated synthesis for difluoromethyl reagents, offering room temperature operation and simplified purification for pharmaceutical intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109694335B reveals a green, solvent-free route for nitrophenylacetonitrile derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112979400A reveals a metal-free route to 2-iodo aryl ethers using alkali metal hydrides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101343263A reveals a green Mn(acac)3 catalyzed route for 5-nitro-4,5-dihydrofuran derivatives, offering high yields and simplified processing for reliable pharmaceutical intermediate suppliers.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply chains.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Novel water-based method for quinoxaline synthesis offers cost-effective, scalable production for pharmaceutical intermediates with high purity and environmental compliance.
Patent CN111233795A details a novel organocatalytic route to chiral gamma-butyrolactones with high stereoselectivity, offering cost-effective API intermediate manufacturing solutions.
Novel metal-free synthesis route for fluorinated heterocycles. Reduces cost and complexity for pharma intermediate manufacturing with high stereoselectivity.
Patent CN113121462B reveals a metal-free, azide-free route for 5-trifluoromethyl-1,2,3-triazoles, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN110746278B reveals a mild, non-metal route for 1,3-diketones. Achieve high purity and cost reduction in API manufacturing without precious metal catalysts.